Suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect by inhibiting histone deacetylation

被引：0
|
作者：
Reddy, P
Maeda, Y
Hotary, K
Dinarello, CA
Ferrara, JL
机构：
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Univ Colorado, Med Ctr, Denver, CO 80202 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2004年 / 10卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2003.12.061
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
29
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [31] CHRONIC GRAFT-VERSUS-HOST DISEASE, OBLITERATIVE BRONCHIOLITIS, AND GRAFT-VERSUS-LEUKEMIA EFFECT - CASE-HISTORIES
    SULLIVAN, KM
    SHULMAN, HM
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (03) : 51 - 62
  • [32] Forodesine treatment and post-transplant graft-versus-host disease in two patients with acute leukemia: Facilitation of graft-versus-leukemia effect?
    Gore, Lia
    Stelijes, Mattias
    Quinones, Ralph
    SEMINARS IN ONCOLOGY, 2007, 34 (06) : S35 - S39
  • [33] Pretreatment of donors with interlukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effect.
    Reddy, P
    Teshima, T
    Hildebrandt, G
    Chen, L
    Ferrara, JLM
    BLOOD, 2002, 100 (11) : 614A - 614A
  • [34] IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects
    Liu, Y.
    Wu, Y.
    Wang, Y.
    Cai, Y.
    Hu, B.
    Bao, G.
    Fang, H.
    Zhao, L.
    Ma, S.
    Cheng, Q.
    Song, Y.
    Liu, Y.
    Zhu, Z.
    Chang, H.
    Yu, X.
    Sun, A.
    Zhang, Y.
    Vignali, D. A. A.
    Wu, D.
    Liu, H.
    LEUKEMIA, 2015, 29 (04) : 939 - 946
  • [35] GRAFT-VERSUS-LEUKEMIA WITHOUT GRAFT VERSUS HOST
    TAYLOR, GM
    BRADLEY, BA
    LANCET, 1979, 2 (8149): : 959 - 960
  • [36] IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects
    Y Liu
    Y Wu
    Y Wang
    Y Cai
    B Hu
    G Bao
    H Fang
    L Zhao
    S Ma
    Q Cheng
    Y Song
    Y Liu
    Z Zhu
    H Chang
    X Yu
    A Sun
    Y Zhang
    D A A Vignali
    D Wu
    H Liu
    Leukemia, 2015, 29 : 939 - 946
  • [37] AML Relapse after Rituximab Treatment for Graft-Versus-Host Disease: Crucial Role for B Cells in Graft-Versus-Host and Graft-Versus-Leukemia
    Gillissen, Marijn Aletta
    Levie, Sophie E.
    de Jong, Greta
    Yasuda, Etsuko
    Bakker, Arjen Q.
    van Helden, Pauline M.
    Jefferson, Douglas M.
    Huisman, Cynthia
    Spits, Hergen
    Hazenberg, Mette D.
    BLOOD, 2015, 126 (23)
  • [38] Graft-versus-infection and graft-versus-leukemia effects after suicide gene therapy of graft-versus-host disease
    Maury, S
    Litvinova, E
    Boyer, O
    Saron, MF
    Salomon, B
    Cohen, J
    Klatzmann, D
    BONE MARROW TRANSPLANTATION, 2002, 29 : S62 - S62
  • [39] Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease
    Toze, CL
    Galal, A
    Barnett, MJ
    Shepherd, JD
    Conneally, EA
    Hogge, DE
    Nantel, SH
    Nevill, TJ
    Sutherland, HJ
    Connors, JM
    Voss, NJ
    Kiss, TL
    Messner, HA
    Lavoie, JC
    Forrest, DL
    Song, KW
    Smith, CA
    Lipton, J
    BONE MARROW TRANSPLANTATION, 2005, 36 (09) : 825 - 830
  • [40] Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease
    C L Toze
    A Galal
    M J Barnett
    J D Shepherd
    E A Conneally
    D E Hogge
    S H Nantel
    T J Nevill
    H J Sutherland
    J M Connors
    N J Voss
    T L Kiss
    H A Messner
    J C Lavoie
    D L Forrest
    K W Song
    C A Smith
    J Lipton
    Bone Marrow Transplantation, 2005, 36 : 825 - 830
12345